Risk of Albuminuria Higher With Dasatinib Than With Other TKIs
Patients with CML have a higher risk of albuminuria if they receive dasatinib rather than other TKIs, a study suggests.
Diagnosis & Disease Information
Vitamin C, D Supplementation During Chemo May Reduce Complications in AML
Taking vitamin C and D during chemotherapy may improve some outcomes for patients with AML, a new study suggests.
Five Things to Know About the New Drug Pricing Negotiations
The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations.
Some Studies Support Use of Cannabis in Pediatric Cancer; More Research is Needed
There is some evidence to support the use of cannabis for symptom management in children with cancer, but there is a lack of evidence on the safety and efficacy of cannabinoids in this patient population, according to researchers.
Bexmarilimab Gets Orphan Drug Status for AML
Bexmarilimab is a first-in-class, humanized monoclonal antibody designed to target Clever-1, a receptor on macrophages that leads to tumor growth and metastasis.
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Birth Weight Linked to Risk of Certain Pediatric Cancers
Birth weight may be associated with the risk of certain pediatric cancers, a new study suggests.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Nilotinib Linked to Higher Risk of Diabetes, Hyperlipidemia in CML Patients
Chronic myeloid leukemia patients treated with nilotinib instead of other tyrosine kinase inhibitors may have a greater risk of developing diabetes and hyperlipidemia.
Increased Risk of Relapse for ALL Patients Living in Extreme Poverty
Among children receiving maintenance therapy for ALL, those living in extreme poverty had a nearly 2-fold greater risk of relapse than those not living in extreme poverty.
- Loading...
Loading...
Next post in Pediatric Cancer
Loading... 
Loading...